NEW YORK — Medical software firm Aiosyn said on Tuesday that it has received a €1.3 million ($1.4 million) grant along with Radboud University Medical Center and Pathologie-DNA to develop deep learning algorithms for cancer detection.
With the funding — which is being provided through the European Union's European Fund for Regional Development program — the Netherlands-based partners will collect and use clinical data to refine and validate algorithms that Aiosyn has developed for breast and skin cancer diagnosis, including one for automated mitosis detection.
The algorithms, Aiosyn said, will be fully integrated into existing digital pathology workflows such as one from Swedish digital pathology firm Sectra.
Additional details of the alliance were not disclosed.
Pathologie-DNA is a collaboration between Pathologie-DNA and the pathology laboratories at Jeroen Bosch Hospital, St. Antonius Hospital, and Rijnstate Hospital. It provides cytopathology, histopathology, molecular diagnostics, and autopsy pathology services.